)
Clever Culture Systems (CC5) investor relations material
Clever Culture Systems Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Market context and need
Environmental monitoring is mandatory in pharmaceutical manufacturing to ensure sterility and patient safety.
Failures in sterility can lead to catastrophic outcomes, including deaths and product recalls, as seen in the 2023 eye drop contamination case.
Validated sterility control systems are critical to prevent microbial contamination before products reach patients.
Solution and technology
APAS Independence uses AI and machine learning to automate microbial quality control, providing faster and more accurate results than manual microbiologist assessments.
The system offers improved data integrity, automatic audit trails, and easy integration with existing workflows.
APAS is designed to meet GMP standards, with over 10 years of microbiology expertise embedded in its algorithms.
Business model and revenue
Each APAS Independence sale can generate up to AU$1.2 million over seven years, combining upfront capital and recurring annual revenue streams.
Revenue split includes 40% from instrumentation, 40% from software licenses (ARR), 15% from service and maintenance, and 5% from implementation.
- Expanded pharma customer base and recurring revenue, but posted a net loss amid lower sales.CC5
H2 2026 - Expanded global pharma base and strong FY27 sales pipeline support growth and financial stability.CC5
Q4 2026 - AI-driven plate assessment transforms pharma QC, unlocking scalable growth and recurring revenue.CC5
Investor presentation - FY26 targets at least 11 APAS® placements, strong cash, and expanding pharma customers.CC5
Q3 2026 - Pivot to pharma market yields first sales, improved liquidity, and positive growth outlook.CC5
H2 2024 - Returned to profitability with strong APAS® Independence sales and expanded pharma market reach.CC5
H2 2025 - Record sales and major pharma contracts drive positive cash flow outlook and $2.5M cash balance.CC5
Q1 2025 - Strategic pivot and pharma sales drive financial strength and positive FY25 outlook.CC5
AGM 2024 - Profitability and pharma adoption accelerate as automation expands with new product launches.CC5
AGM 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)